Supernus Pharmaceuticals
SUPN
#4517
Rank
โ‚น148.53 B
Marketcap
โ‚น2,696
Share price
0.91%
Change (1 day)
14.29%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น30.06 B

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น30.06 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น29.64 B-56.11%
2022-12-31โ‚น67.54 B3.79%
2021-12-31โ‚น65.08 B17.4%
2020-12-31โ‚น55.43 B37.87%
2019-12-31โ‚น40.20 B10.14%
2018-12-31โ‚น36.50 B264.18%
2017-12-31โ‚น10.02 B25.2%
2016-12-31โ‚น8.00 B19.75%
2015-12-31โ‚น6.68 B9.95%
2014-12-31โ‚น6.08 B26.91%
2013-12-31โ‚น4.79 B140.25%
2012-12-31โ‚น1.99 B-14.87%
2011-12-31โ‚น2.34 B-42.78%
2010-12-31โ‚น4.09 B2.14%
2009-12-31โ‚น4.00 B-3.87%
2008-12-31โ‚น4.16 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น86.07 B 186.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.885 T 16,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.508 T 21,546.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.806 T 9,235.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.190 T 30,468.54%๐Ÿ‡บ๐Ÿ‡ธ USA